Biotech Acquisition Company (BIOTU) Prices $200M IPO


Jan 25, 2021 INTEL by Kristi Marvin
Biotech Acquisition Company announced the pricing of its $200 million IPO this evening and its shares are expected to begin trading on the Nasdaq under the symbol “BIOTU” Tuesday, January 26.
The new company intends to focus their search on target businesses in the healthcare sector, with a particular focus on life sciences/biotechnology, healthcare information technology, medical technology and technology-enabled healthcare services. Biotech Acquisition Company is led by Chief Executive Officer and Chairman Dr. Michael Shleifer, COO Ivan Jarry, Chief In